In his doctoral dissertation, Marlon Machal studied how symptom checkers, connected devices, autoinjectors, and AI-powered autoinjectors enable patient self-care while meeting regulatory standards in the US and EU. He found that these technologies improve patient health and healthcare delivery but face challenges in cybersecurity, interoperability, and regulatory compliance. His dissertation highlights the need for agile regulatory frameworks and patient-centered approaches to ensure safety and effectiveness. These findings aim to benefit patients, manufacturers, and regulators by promoting safer self-care solutions and accelerating approval processes for innovative medical devices.
The doctoral dissertation of MSc (Information and Service Management) Marlon Machal in the field of Medicine Bioscience and Biomedical Engineering titled Enhancing Regulatory Compliance and Safety in Patient Self-Care: An Approach to Symptom Checkers, Connected Devices, Autoinjectors and AI-Powered Autoinjectors will be publicly examined at the Faculty of Medicine and Health Technology at Tampere University on 30 January 2026.
The Opponent will be Dr Elaine Harris from the Technological University Dublin, Ireland. The Custos will be Professor Alpo Värri from the Faculty of Medicine and Health Technology, Tampere University.